Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · GBL

Is GBL legal in Saudi Arabia?

Confirmed against a primary sourceVerified September 20, 2026
Legal status
GBL is both named in the schedules and governed by a special prohibition in Saudi Arabia. It appears at Schedule II Category E of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, the locally controlled psychotropics list, and General Rule 10 of those schedules provides «يحظر استيراد مادة GBL... أو تصديرها أو إنتاجها أو صنعها...», the import, export, production and manufacture of GBL, among the other conduct the rule lists, is prohibited. The rule prints its own exceptions, and they are the part that decides most industrial cases: filled final products are excepted, as are licensed scientific, research, industrial and commercial uses under the chemical management rules. GBL is a bulk solvent as well as a prodrug of GHB, and a scheme that banned it outright would stop legitimate manufacturing, which is why the exceptions exist rather than being an oversight. M/39 Articles 1 and 70 to 71 are cited for identification and for keeping the attached schedules current.
Consequences if caught
A Schedule II Category E placement brings GBL inside Article 37(I), and that article states no quantity at all. There is no weight threshold in it: the conduct named is smuggling, receipt from a smuggler, and import, export, manufacture, production, extraction or cultivation with intent to promote, together with the repeat promotion histories the article sets out. Death under Article 37(I) is a statutory ta'zir penalty and it is not mandatory, because Article 37(II) gives the court the power to reduce it; where the court does reduce, the substitute is a prison term of not less than fifteen years with the lashes and the fine the article states. No express life imprisonment wording was found anywhere in M/39. Articles 38 to 41 are cited as the tiers below Article 37 for this placement. The General Rule 10 exceptions turn on licence and product form rather than on amount, so a drum held under a chemical management licence and a bottle carried for consumption are distinguished by authorisation, not by volume.
If prescribed or medical
The Saudi traveller rule is a permit rule rather than a prescription rule. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. GBL sits inside the narcotics law as a Schedule II Category E substance subject to the General Rule 10 prohibition, and no Saudi dispensing route and no medicinal GBL product was recorded, so nothing here should be read as saying a clearance would issue for personal carriage. The licensed scientific, research, industrial and commercial exceptions are business licensing routes rather than traveller routes.
Documentation
There is no traveller permit for this substance, and a cleaning, solvent or nail product labelling does not create one. An industrial or research user relies on the licence the General Rule 10 exceptions describe, which is held by the entity rather than carried by a person. For any controlled medicine, apply through the SFDA Controlled Drugs System before travelling, carry the clearance and not the prescription alone, bring it in its original dispensing packaging with the prescription and a medical report translated into Arabic and dated less than six months before travel, and declare it at customs; advance electronic clearance has been required since 1 November 2025. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The Schedule II Category E entry and General Rule 10 were read in the 4 September 2026 schedules on 17 September 2026.
Primary sources
  • Saudi Arabia, Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, Articles 1, 37 to 41 and 70 to 71, with GBL placed at Schedule II Category E and subject to General Rule 10 of the schedules attached to the Law in the version issued on 4 September 2026, which prohibits the listed conduct subject to its printed exceptions for filled final products and licensed scientific, research, industrial and commercial use
  • the schedules were read at https://sfda.gov.sa/sites/default/files/2026-09/%D8%A7%D9%84%D8%AC%D8%AF%D8%A7%D9%88%D9%84%20%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D9%81%D9%82%D8%A9%20%D9%84%D9%86%D8%B8%D8%A7%D9%85%20%D9%85%D9%83%D8%A7%D9%81%D8%AD%D8%A9%20%D8%A7%D9%84%D9%85%D8%AE%D8%AF%D8%B1%D8%A7%D8%AA%20%D9%88%D8%A7%D9%84%D9%85%D8%A4%D8%AB%D8%B1%D8%A7%D8%AA%20%D8%A7%D9%84%D8%B9%D9%82%D9%84%D9%8A%D8%A9%202026.pdf, the Saudi Food and Drug Authority copy, and the penalty articles at https://www.moh.gov.sa/eServices/Licences/Documents/17.pdf, the Ministry of Health copy of M/39
  • read as at 17 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

GBL in related jurisdictions

Other substances confirmed in Saudi Arabia